Several prospective studies show high sensitivity-CRP (hs-CRP) levels are a good predictor of the future advancement of type 2 diabetes in nondiabetic individuals regardless of fat distribution and insulin resistance. The gene discussed is CRP; the disease is type 2 diabetes mellitus.